SARS-CoV-2 Mpro-IN-13

• UNSPSC Description:

  SARS-CoV-2 Mpro-IN-13 (compound 20j) is a covalent SARS-CoV-2 Protease Mpro inhibitor with an IC50 value of 19.0 nM. SARS-CoV-2 Mpro-IN-13 processes antiviral activity with an EC50 value of 138.1 nM[1].

• Target Antigen:

  SARS-CoV

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/sars-cov-2-mpro-in-13.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(C1CCC(F)(F)CC1)N[C@H](C2CCCCC2)C(N[C@H](COC)C(NC3(C(C(NCC4=NC=CS4)=O)=O)CCC3)=O)=O

• Molecular Weight:

  625.73

• References & Citations:

  [1]Huang Q,et al. Discovery of α-Ketoamide inhibitors of SARS-CoV-2 main protease derived from quaternized P1 groups. Bioorg Chem. 2023 Dec 6;143:107001.|[2]Qiao Huang, et al. Discovery of α-Ketoamide inhibitors of SARS-CoV-2 main protease derived from quaternized P1 groups. Bioorg Chem. 2023 Dec 6:143:107001.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported